Zimmer Biomet Holdings Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Zimmer Biomet Holdings Inc in the third quarter 2026?
Zimmer Biomet Holdings Inc achieved a return on average equity (ROE) of 6.05 % in its third quarter 2026, which is below Zimmer Biomet Holdings Inc 's average return on equity, which stands at 6.39%.

ROE decreased relative to the period ending , due to the decline in net income.

Within the Medical Equipment & Supplies industry 49 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the second quarter 2026 from 1870 to 1889.

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Equity Change	-0.32 %	0.78 %	2.24 %	1.84 %	-
Y / Y Net Income Change	-17.13 %	30.12 %	30.5 %	-42.52 %	-7.26 %
Net Income (TTM) in Millions	768	807	761	705	807
Return On Equity (TTM)	6.05 %	6.36 %	6 %	5.6 %	6.44 %
ZBH's Total Ranking	# 1889	# 1870	# 1662	# 1667	#
Equity (TTM) in Millions	12,726	12,633	12,682	12,706	12,766
Seq. Equity Change	0.74 %	-0.39 %	-0.19 %	-0.47 %	1.85 %
Seq. Net Income Change	-4.01 %	-16.24 %	72.68 %	-40.31 %	50.72 %

Back to ZBH Management Effectiveness >> ZBH's 5 Years Annual ROE >> Compare ZBH ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	# 50
Sector	# 160
Overall	# 1889

Return On Equity Statistics
High	Average	Low
17.11 %	6.39 %	-3.19 %
(Dec 31 2017)		(Dec 31 2018)

ZBH Annual Return On Equity	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Equity in Millions	12,706	12,476	12,488	12,027	12,666
Y / Y Equity Change	1.84 %	-0.1 %	3.83 %	-5.05 %	3.83 %
Net Income in Millions	705	905	1,025	232	402
Y / Y Net Income Change	-22.1 %	-11.69 %	341.09 %	-42.2 %	-
Return On Equity	5.55 %	7.26 %	8.21 %	1.93 %	3.17 %

Back to ZBH Management Effectiveness >> ZBH's 5 Years Annual ROE >> Compare ZBH ROE to its Competitors

Annual Roe Comment

In 2025 ROE decreased compared to the previous year to 5.55 %, due to deterioration of net income.

More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
ZBH's' Return on Equity at Yahoo Finance
ZBH's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for ZBH's Competitors
Subscribers only: Roe for Zimmer Biomet Holdings Inc 's Suppliers
Subscribers only: Return On Equity for ZBH's Customers

Companies with similar Return On Equity at Sep 30 2026, within Healthcare Sector	ROE
Ensign Group Inc	16.62 %
Lemaitre Vascular Inc	15.81 %
Stryker Corp	15.61 %
Quest Diagnostics Inc	15.22 %
Regeneron Pharmaceuticals Inc	15.07 %
Bio rad Laboratories Inc	14.07 %
Boston Scientific Corporation	13.75 %
Inspire Medical Systems inc	12.49 %
Haemonetics Corporation	12.07 %
Labcorp Holdings Inc	11.55 %
Henry Schein Inc	11.29 %
Medinotec Inc	10.97 %
Tactile Systems Technology Inc	10.73 %
Penumbra Inc	10.44 %
Teleflex Incorporated	9.67 %
Merit Medical Systems Inc	9.65 %
U S Physical Therapy Inc	9.48 %
Abbott Laboratories	9.00 %
Pacific Health Care Organization Inc	8.10 %
Incyte Corporation	7.08 %
Conmed Corporation	7.07 %
Teva Pharmaceutical Industries Limited	6.37 %
Integer Holdings Corporation	6.02 %
Avantor Inc	5.96 %
Ligand Pharmaceuticals Incorporated	5.22 %
Lifestance Health Group Inc	4.82 %
Jazz Pharmaceuticals Plc	4.62 %
Pfizer Inc	4.62 %
Innovage Holding Corp	4.52 %
Icu Medical Inc	2.81 %

Date modified: 2026-11-07T13:17:52+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.